Scarica l'app Stockscreener
1.41
0.00%
0.00
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Ocugen Inc Borsa (OCGN) Ultime notizie
How cyclical is Ocugen Inc. (2H51) stock compared to rivalsWeekly Trade Review & Fast Gain Stock Trading Tips - mfd.ru
Aug EndMonth: Is Ocugen Inc a momentum stockJuly 2025 Market Mood & Risk Controlled Stock Alerts - baoquankhu1.vn
Highs Report: Is Ocugen Inc a cyclical or defensive stock2025 Retail Activity & Free Risk Controlled Daily Trade Plans - baoquankhu1.vn
What The Latest Developments Mean For Ocugen’s Changing Valuation Story - Yahoo Finance
Ocugen foresees gene-agnostic therapies advancing blindness treatment - Traders Union
Ocugen appoints Rita Johnson-Greene as chief financial officer - Pennsylvania Business Report -
Ocugen Bolsters Leadership Ahead of Critical Regulatory Milestone - AD HOC NEWS
Ocugen appoints Rita Johnson-Greene as new CFO By Investing.com - Investing.com South Africa
Ocugen appoints Rita Johnson-Greene as chief financial officer By Investing.com - Investing.com Canada
Ocugen Appoints Rita Johnson-Greene as New Chief Financial Officer - TipRanks
Ocugen (OCGN) Appoints New CFO, Shares Rise - GuruFocus
Ocugen (OCGN) Appoints New CFO to Strengthen Leadership Team - GuruFocus
Ocugen, Inc. Appoints New Chief Financial Officer - TradingView
Ocugen Names Rita Johnson-Greene as CFO - marketscreener.com
Ocugen appoints Rita Johnson-Greene as new CFO - Investing.com
Ocugen Appoints Rita Johnson-Greene to Chief Financial Officer - citybiz
Ocugen, Inc. Appoints Rita Johnson-Greene as Chief Financial Officer - Quiver Quantitative
Ocugen Appoints Rita Johnson-Greene To Chief Financial Officer - TradingView
Cell and gene therapy exec Rita Johnson-Greene joins Ocugen as CFO - Stock Titan
Ocugen grants CEO new performance-based equity award - MSN
Wall Street Recap: Can Ocugen Inc be recession proof2025 Price Action Summary & Free Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Breakout Move: Will Ocugen Inc stock recover after earningsJuly 2025 Levels & Real-Time Market Trend Scan - baoquankhu1.vn
Ocugen’s Gene Therapy Progress and Funding Extend Runway - AD HOC NEWS
Ocugen Shares Stabilize Following Recent Equity Offering - AD HOC NEWS
Trade Report: Can Ocugen Inc be recession proofWeekly Investment Summary & Verified Swing Trading Watchlist - baoquankhu1.vn
Ocugen Stock Lifts Retail Investor Confidence As Q4 Revenue Crushes Estimates - MSN
Ocugen Doses First Patient in Pivotal Trial for Stargardt Gene Therapy - MSN
Ocugen prices $22.5M common stock offering at $1.50 per share - MSN
What are analysts price targets for Ocugen IncJuly 2025 Volume & Long Hold Capital Preservation Tips - baoquankhu1.vn
Valuation Update: Can Belite Bio Inc Depositary Receipt deliver alphaWeekly Market Outlook & Smart Allocation Stock Tips - baoquankhu1.vn
RSI Check: Can Ocugen Inc weather a recessionWeekly Trading Summary & Community Consensus Trade Alerts - baoquankhu1.vn
Ocugen’s Gene Therapy Candidate Shows Promise in Early-Stight Loss Trial - AD HOC NEWS
Ocugen’s Stargardt Gene Therapy OCU410ST Provides +6-Letter Gain in BCVA-Evaluable Patients in Phase 1 Trial - NeurologyLive
Ocugen’s Gene Therapy OCU410ST Continues to Show Efficacy in Phase 1 Stargardt Disease Trial - CGTLive®
Ocugen stock surges 75% year to date: What's in store for 2026? - MSN
Ocugen Raises $20.9M to Extend Cash Runway Into Late 2026 - MyChesCo
Macro Review: Is Ocugen Inc forming a double bottom2025 Volatility Report & Growth Oriented Trading Recommendations - baoquankhu1.vn
Ocugen Stock: A Turnaround Fueled by Promising Trial Data - AD HOC NEWS
Ocugen’s Clinical Pipeline Takes Center Stage Following Capital Raise - AD HOC NEWS
How The Narrative Around Ocugen (OCGN) Is Shifting After The Latest Price Target Change - Yahoo Finance
Ocugen Secures Financial Runway Through Strategic Capital Raise - AD HOC NEWS
Ocugen Secures Funding to Advance Gene Therapy Pipeline - AD HOC NEWS
Ocugen Secures Funding at a Short-Term Cost to Shareholders - AD HOC NEWS
Ocugen Shares Defy Dilution Fears on Strong Clinical Data - AD HOC NEWS
Ocugen, Inc. Announces Closing of $22.5 Million Underwritten Registered Direct Offering of Common Stock - Sahm
Ocugen closes $22.5 million registered direct offering By Investing.com - Investing.com South Africa
Ocugen Secures Financial Runway Through 2026 - AD HOC NEWS
How Fresh Capital And Positive OCU410 Data At Ocugen (OCGN) Has Changed Its Investment Story - Yahoo Finance
Ocugen strengthens balance sheet with new equity financing - TipRanks
Ocugen, Inc. Closes $22.5 Million Stock Offering - TradingView
Ocugen closes $22.5 million registered direct offering - Investing.com
1.12%
0.87%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):